Polypathology-associated neurodegeneration after remote head injury

Clin Neuropathol. 2023 Nov-Dec;42(6):201-211. doi: 10.5414/NP301576.

Abstract

Traumatic brain injury (TBI) is a leading cause of morbidity and mortality worldwide. TBI ranges from mild to severe and is a recognized risk factor for later neurodegenerative conditions including chronic traumatic encephalopathy (CTE), Alzheimer disease (AD) and Parkinson disease (PD). The development of CTE is typically associated with repetitive exposure to mild TBI (mTBI), while a single moderate-to-severe TBI is considered a risk factor for AD and PD. Polypathology is common, and the lines between these conditions post TBI can be somewhat blurred. The mechanisms through which TBI leads to future neurodegeneration are not well understood. Heterogeneity and distance from the injury or injuries and individual genetic and environmental factors make clinical studies difficult. We present the case of an 82-year-old man who died 4 years after developing a phenotypically mixed dementia with neuropsychiatric features and parkinsonism. He had a remote history of a severe TBI 40 years prior, following a road traffic accident which caused a large right frontal injury, requiring neurosurgical intervention. Post-mortem neuropathological examination demonstrated abnormal phosphorylated-Tau (p-Tau), beta-amyloid plaques (Aβ) and α-synuclein deposition. Spatial immunohistochemical analysis demonstrated increased perivascular accumulation of p-Tau with blood-brain barrier (BBB) disruption at the site of injury, which decreased with distance from the injury site. The appearances are suggestive of initial vascular disruption with persisting BBB disruption as a driver of the pathology.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Alzheimer Disease* / pathology
  • Amyloid beta-Peptides
  • Brain / pathology
  • Brain Injuries, Traumatic* / complications
  • Chronic Traumatic Encephalopathy* / pathology
  • Humans
  • Male
  • tau Proteins / metabolism

Substances

  • tau Proteins
  • Amyloid beta-Peptides